We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“We've known for a long time that weight loss is important for preventing atrial fibrillation or increasing the success rates of the different treatments we use. Probably in some studies, weight loss has been as effective as antiarrhythmics.”
“Our findings were surprising. While we believed this therapy could be beneficial, the observed magnitude of effect on ablation outcome was much greater than we expected. We acknowledge that this was a small study, so statistical variability could allow for the true effect to be smaller than what we observed. Even then, the magnitude of the effect we observed was so large that this will most likely stand the test of time and represent a meaningful improvement in ablation outcomes for the strategy of adjunctive and risk‑factor modification when applied before the procedure, as done in LEAF.”
“Currently, only about 50% of patients with persistent AFib and about 70% with paroxysmal, or episodic, AFib remain free of AFib after ablation. In LEAF, 83% of AFib patients who received liraglutide in addition to usual care remained AFib-free a year after their ablations.”
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
Goldberger et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: